Click for best price
Active Pharmaceutical Ingredients API CDMO Market Size, Share 2024
The global Active Pharmaceutical Ingredients (API) CDMO market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Macromolecular API Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Active Pharmaceutical Ingredients (API) CDMO include Recipharm, Cambrex Corporation, Patheon (Thermo Fisher Scientific), CordenPharma, Lonza, Siegfried, Catalent, Boehringer Ingelheim and Piramal Group, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Active Pharmaceutical Ingredients (API) CDMO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Active Pharmaceutical Ingredients (API) CDMO. This report contains market size and forecasts of Active Pharmaceutical Ingredients (API) CDMO in global, including the following market information:
Global Active Pharmaceutical Ingredients (API) CDMO Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global top five companies in 2023 (%)
We has surveyed the Active Pharmaceutical Ingredients (API) CDMO companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Active Pharmaceutical Ingredients (API) CDMO Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Active Pharmaceutical Ingredients (API) CDMO Market Segment Percentages, by Type, 2023 (%)
Macromolecular API
Small Molecule API
Global Active Pharmaceutical Ingredients (API) CDMO Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Active Pharmaceutical Ingredients (API) CDMO Market Segment Percentages, by Application, 2023 (%)
Clinical
Commercial
Others
Global Active Pharmaceutical Ingredients (API) CDMO Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Active Pharmaceutical Ingredients (API) CDMO Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Active Pharmaceutical Ingredients (API) CDMO revenues in global market, 2019-2024 (estimated), ($ millions)
Key companies Active Pharmaceutical Ingredients (API) CDMO revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Recipharm
Cambrex Corporation
Patheon (Thermo Fisher Scientific)
CordenPharma
Lonza
Siegfried
Catalent
Boehringer Ingelheim
Piramal Group
AbbVie
SGS Quay Pharmaceuticals
Aenova Group
Curia
Sterling Pharma Solutions
Eurofins CDMO
Outline of Major Chapters:
Chapter 1: Introduces the definition of Active Pharmaceutical Ingredients (API) CDMO, market overview.
Chapter 2: Global Active Pharmaceutical Ingredients (API) CDMO market size in revenue.
Chapter 3: Detailed analysis of Active Pharmaceutical Ingredients (API) CDMO company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Active Pharmaceutical Ingredients (API) CDMO in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Active Pharmaceutical Ingredients (API) CDMO Market, Global Outlook and Forecast 2024-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
107 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Active Pharmaceutical Ingredients (API) CDMO Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Active Pharmaceutical Ingredients (API) CDMO Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Active Pharmaceutical Ingredients (API) CDMO Overall Market Size
2.1 Global Active Pharmaceutical Ingredients (API) CDMO Market Size: 2023 VS 2030
2.2 Global Active Pharmaceutical Ingredients (API) CDMO Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Active Pharmaceutical Ingredients (API) CDMO Players in Global Market
3.2 Top Global Active Pharmaceutical Ingredients (API) CDMO Companies Ranked by Revenue
3.3 Global Active Pharmaceutical Ingredients (API) CDMO Revenue by Companies
3.4 Top 3 and Top 5 Active Pharmaceutical Ingredients (API) CDMO Companies in Global Market, by Revenue in 2023
3.5 Global Companies Active Pharmaceutical Ingredients (API) CDMO Product Type
3.6 Tier 1, Tier 2 and Tier 3 Active Pharmaceutical Ingredients (API) CDMO Players in Global Market
3.6.1 List of Global Tier 1 Active Pharmaceutical Ingredients (API) CDMO Companies
3.6.2 List of Global Tier 2 and Tier 3 Active Pharmaceutical Ingredients (API) CDMO Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Active Pharmaceutical Ingredients (API) CDMO Market Size Markets, 2023 & 2030
4.1.2 Macromolecular API
4.1.3 Small Molecule API
4.2 By Type - Global Active Pharmaceutical Ingredients (API) CDMO Revenue & Forecasts
4.2.1 By Type - Global Active Pharmaceutical Ingredients (API) CDMO Revenue, 2019-2024
4.2.2 By Type - Global Active Pharmaceutical Ingredients (API) CDMO Revenue, 2025-2030
4.2.3 By Type - Global Active Pharmaceutical Ingredients (API) CDMO Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Active Pharmaceutical Ingredients (API) CDMO Market Size, 2023 & 2030
5.1.2 Clinical
5.1.3 Commercial
5.1.4 Others
5.2 By Application - Global Active Pharmaceutical Ingredients (API) CDMO Revenue & Forecasts
5.2.1 By Application - Global Active Pharmaceutical Ingredients (API) CDMO Revenue, 2019-2024
5.2.2 By Application - Global Active Pharmaceutical Ingredients (API) CDMO Revenue, 2025-2030
5.2.3 By Application - Global Active Pharmaceutical Ingredients (API) CDMO Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Active Pharmaceutical Ingredients (API) CDMO Market Size, 2023 & 2030
6.2 By Region - Global Active Pharmaceutical Ingredients (API) CDMO Revenue & Forecasts
6.2.1 By Region - Global Active Pharmaceutical Ingredients (API) CDMO Revenue, 2019-2024
6.2.2 By Region - Global Active Pharmaceutical Ingredients (API) CDMO Revenue, 2025-2030
6.2.3 By Region - Global Active Pharmaceutical Ingredients (API) CDMO Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Active Pharmaceutical Ingredients (API) CDMO Revenue, 2019-2030
6.3.2 US Active Pharmaceutical Ingredients (API) CDMO Market Size, 2019-2030
6.3.3 Canada Active Pharmaceutical Ingredients (API) CDMO Market Size, 2019-2030
6.3.4 Mexico Active Pharmaceutical Ingredients (API) CDMO Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Active Pharmaceutical Ingredients (API) CDMO Revenue, 2019-2030
6.4.2 Germany Active Pharmaceutical Ingredients (API) CDMO Market Size, 2019-2030
6.4.3 France Active Pharmaceutical Ingredients (API) CDMO Market Size, 2019-2030
6.4.4 U.K. Active Pharmaceutical Ingredients (API) CDMO Market Size, 2019-2030
6.4.5 Italy Active Pharmaceutical Ingredients (API) CDMO Market Size, 2019-2030
6.4.6 Russia Active Pharmaceutical Ingredients (API) CDMO Market Size, 2019-2030
6.4.7 Nordic Countries Active Pharmaceutical Ingredients (API) CDMO Market Size, 2019-2030
6.4.8 Benelux Active Pharmaceutical Ingredients (API) CDMO Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Active Pharmaceutical Ingredients (API) CDMO Revenue, 2019-2030
6.5.2 China Active Pharmaceutical Ingredients (API) CDMO Market Size, 2019-2030
6.5.3 Japan Active Pharmaceutical Ingredients (API) CDMO Market Size, 2019-2030
6.5.4 South Korea Active Pharmaceutical Ingredients (API) CDMO Market Size, 2019-2030
6.5.5 Southeast Asia Active Pharmaceutical Ingredients (API) CDMO Market Size, 2019-2030
6.5.6 India Active Pharmaceutical Ingredients (API) CDMO Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Active Pharmaceutical Ingredients (API) CDMO Revenue, 2019-2030
6.6.2 Brazil Active Pharmaceutical Ingredients (API) CDMO Market Size, 2019-2030
6.6.3 Argentina Active Pharmaceutical Ingredients (API) CDMO Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Active Pharmaceutical Ingredients (API) CDMO Revenue, 2019-2030
6.7.2 Turkey Active Pharmaceutical Ingredients (API) CDMO Market Size, 2019-2030
6.7.3 Israel Active Pharmaceutical Ingredients (API) CDMO Market Size, 2019-2030
6.7.4 Saudi Arabia Active Pharmaceutical Ingredients (API) CDMO Market Size, 2019-2030
6.7.5 UAE Active Pharmaceutical Ingredients (API) CDMO Market Size, 2019-2030
7 Active Pharmaceutical Ingredients (API) CDMO Companies Profiles
7.1 Recipharm
7.1.1 Recipharm Company Summary
7.1.2 Recipharm Business Overview
7.1.3 Recipharm Active Pharmaceutical Ingredients (API) CDMO Major Product Offerings
7.1.4 Recipharm Active Pharmaceutical Ingredients (API) CDMO Revenue in Global Market (2019-2024)
7.1.5 Recipharm Key News & Latest Developments
7.2 Cambrex Corporation
7.2.1 Cambrex Corporation Company Summary
7.2.2 Cambrex Corporation Business Overview
7.2.3 Cambrex Corporation Active Pharmaceutical Ingredients (API) CDMO Major Product Offerings
7.2.4 Cambrex Corporation Active Pharmaceutical Ingredients (API) CDMO Revenue in Global Market (2019-2024)
7.2.5 Cambrex Corporation Key News & Latest Developments
7.3 Patheon (Thermo Fisher Scientific)
7.3.1 Patheon (Thermo Fisher Scientific) Company Summary
7.3.2 Patheon (Thermo Fisher Scientific) Business Overview
7.3.3 Patheon (Thermo Fisher Scientific) Active Pharmaceutical Ingredients (API) CDMO Major Product Offerings
7.3.4 Patheon (Thermo Fisher Scientific) Active Pharmaceutical Ingredients (API) CDMO Revenue in Global Market (2019-2024)
7.3.5 Patheon (Thermo Fisher Scientific) Key News & Latest Developments
7.4 CordenPharma
7.4.1 CordenPharma Company Summary
7.4.2 CordenPharma Business Overview
7.4.3 CordenPharma Active Pharmaceutical Ingredients (API) CDMO Major Product Offerings
7.4.4 CordenPharma Active Pharmaceutical Ingredients (API) CDMO Revenue in Global Market (2019-2024)
7.4.5 CordenPharma Key News & Latest Developments
7.5 Lonza
7.5.1 Lonza Company Summary
7.5.2 Lonza Business Overview
7.5.3 Lonza Active Pharmaceutical Ingredients (API) CDMO Major Product Offerings
7.5.4 Lonza Active Pharmaceutical Ingredients (API) CDMO Revenue in Global Market (2019-2024)
7.5.5 Lonza Key News & Latest Developments
7.6 Siegfried
7.6.1 Siegfried Company Summary
7.6.2 Siegfried Business Overview
7.6.3 Siegfried Active Pharmaceutical Ingredients (API) CDMO Major Product Offerings
7.6.4 Siegfried Active Pharmaceutical Ingredients (API) CDMO Revenue in Global Market (2019-2024)
7.6.5 Siegfried Key News & Latest Developments
7.7 Catalent
7.7.1 Catalent Company Summary
7.7.2 Catalent Business Overview
7.7.3 Catalent Active Pharmaceutical Ingredients (API) CDMO Major Product Offerings
7.7.4 Catalent Active Pharmaceutical Ingredients (API) CDMO Revenue in Global Market (2019-2024)
7.7.5 Catalent Key News & Latest Developments
7.8 Boehringer Ingelheim
7.8.1 Boehringer Ingelheim Company Summary
7.8.2 Boehringer Ingelheim Business Overview
7.8.3 Boehringer Ingelheim Active Pharmaceutical Ingredients (API) CDMO Major Product Offerings
7.8.4 Boehringer Ingelheim Active Pharmaceutical Ingredients (API) CDMO Revenue in Global Market (2019-2024)
7.8.5 Boehringer Ingelheim Key News & Latest Developments
7.9 Piramal Group
7.9.1 Piramal Group Company Summary
7.9.2 Piramal Group Business Overview
7.9.3 Piramal Group Active Pharmaceutical Ingredients (API) CDMO Major Product Offerings
7.9.4 Piramal Group Active Pharmaceutical Ingredients (API) CDMO Revenue in Global Market (2019-2024)
7.9.5 Piramal Group Key News & Latest Developments
7.10 AbbVie
7.10.1 AbbVie Company Summary
7.10.2 AbbVie Business Overview
7.10.3 AbbVie Active Pharmaceutical Ingredients (API) CDMO Major Product Offerings
7.10.4 AbbVie Active Pharmaceutical Ingredients (API) CDMO Revenue in Global Market (2019-2024)
7.10.5 AbbVie Key News & Latest Developments
7.11 SGS Quay Pharmaceuticals
7.11.1 SGS Quay Pharmaceuticals Company Summary
7.11.2 SGS Quay Pharmaceuticals Business Overview
7.11.3 SGS Quay Pharmaceuticals Active Pharmaceutical Ingredients (API) CDMO Major Product Offerings
7.11.4 SGS Quay Pharmaceuticals Active Pharmaceutical Ingredients (API) CDMO Revenue in Global Market (2019-2024)
7.11.5 SGS Quay Pharmaceuticals Key News & Latest Developments
7.12 Aenova Group
7.12.1 Aenova Group Company Summary
7.12.2 Aenova Group Business Overview
7.12.3 Aenova Group Active Pharmaceutical Ingredients (API) CDMO Major Product Offerings
7.12.4 Aenova Group Active Pharmaceutical Ingredients (API) CDMO Revenue in Global Market (2019-2024)
7.12.5 Aenova Group Key News & Latest Developments
7.13 Curia
7.13.1 Curia Company Summary
7.13.2 Curia Business Overview
7.13.3 Curia Active Pharmaceutical Ingredients (API) CDMO Major Product Offerings
7.13.4 Curia Active Pharmaceutical Ingredients (API) CDMO Revenue in Global Market (2019-2024)
7.13.5 Curia Key News & Latest Developments
7.14 Sterling Pharma Solutions
7.14.1 Sterling Pharma Solutions Company Summary
7.14.2 Sterling Pharma Solutions Business Overview
7.14.3 Sterling Pharma Solutions Active Pharmaceutical Ingredients (API) CDMO Major Product Offerings
7.14.4 Sterling Pharma Solutions Active Pharmaceutical Ingredients (API) CDMO Revenue in Global Market (2019-2024)
7.14.5 Sterling Pharma Solutions Key News & Latest Developments
7.15 Eurofins CDMO
7.15.1 Eurofins CDMO Company Summary
7.15.2 Eurofins CDMO Business Overview
7.15.3 Eurofins CDMO Active Pharmaceutical Ingredients (API) CDMO Major Product Offerings
7.15.4 Eurofins CDMO Active Pharmaceutical Ingredients (API) CDMO Revenue in Global Market (2019-2024)
7.15.5 Eurofins CDMO Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Active Pharmaceutical Ingredients (API) CDMO Market Opportunities & Trends in Global Market
Table 2. Active Pharmaceutical Ingredients (API) CDMO Market Drivers in Global Market
Table 3. Active Pharmaceutical Ingredients (API) CDMO Market Restraints in Global Market
Table 4. Key Players of Active Pharmaceutical Ingredients (API) CDMO in Global Market
Table 5. Top Active Pharmaceutical Ingredients (API) CDMO Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Active Pharmaceutical Ingredients (API) CDMO Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Active Pharmaceutical Ingredients (API) CDMO Revenue Share by Companies, 2019-2024
Table 8. Global Companies Active Pharmaceutical Ingredients (API) CDMO Product Type
Table 9. List of Global Tier 1 Active Pharmaceutical Ingredients (API) CDMO Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Active Pharmaceutical Ingredients (API) CDMO Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Active Pharmaceutical Ingredients (API) CDMO Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Active Pharmaceutical Ingredients (API) CDMO Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Active Pharmaceutical Ingredients (API) CDMO Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Active Pharmaceutical Ingredients (API) CDMO Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Active Pharmaceutical Ingredients (API) CDMO Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Active Pharmaceutical Ingredients (API) CDMO Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Active Pharmaceutical Ingredients (API) CDMO Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Active Pharmaceutical Ingredients (API) CDMO Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Active Pharmaceutical Ingredients (API) CDMO Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Active Pharmaceutical Ingredients (API) CDMO Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Active Pharmaceutical Ingredients (API) CDMO Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Active Pharmaceutical Ingredients (API) CDMO Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Active Pharmaceutical Ingredients (API) CDMO Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Active Pharmaceutical Ingredients (API) CDMO Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Active Pharmaceutical Ingredients (API) CDMO Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Active Pharmaceutical Ingredients (API) CDMO Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Active Pharmaceutical Ingredients (API) CDMO Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Active Pharmaceutical Ingredients (API) CDMO Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Active Pharmaceutical Ingredients (API) CDMO Revenue, (US$, Mn), 2025-2030
Table 30. Recipharm Company Summary
Table 31. Recipharm Active Pharmaceutical Ingredients (API) CDMO Product Offerings
Table 32. Recipharm Active Pharmaceutical Ingredients (API) CDMO Revenue (US$, Mn) & (2019-2024)
Table 33. Recipharm Key News & Latest Developments
Table 34. Cambrex Corporation Company Summary
Table 35. Cambrex Corporation Active Pharmaceutical Ingredients (API) CDMO Product Offerings
Table 36. Cambrex Corporation Active Pharmaceutical Ingredients (API) CDMO Revenue (US$, Mn) & (2019-2024)
Table 37. Cambrex Corporation Key News & Latest Developments
Table 38. Patheon (Thermo Fisher Scientific) Company Summary
Table 39. Patheon (Thermo Fisher Scientific) Active Pharmaceutical Ingredients (API) CDMO Product Offerings
Table 40. Patheon (Thermo Fisher Scientific) Active Pharmaceutical Ingredients (API) CDMO Revenue (US$, Mn) & (2019-2024)
Table 41. Patheon (Thermo Fisher Scientific) Key News & Latest Developments
Table 42. CordenPharma Company Summary
Table 43. CordenPharma Active Pharmaceutical Ingredients (API) CDMO Product Offerings
Table 44. CordenPharma Active Pharmaceutical Ingredients (API) CDMO Revenue (US$, Mn) & (2019-2024)
Table 45. CordenPharma Key News & Latest Developments
Table 46. Lonza Company Summary
Table 47. Lonza Active Pharmaceutical Ingredients (API) CDMO Product Offerings
Table 48. Lonza Active Pharmaceutical Ingredients (API) CDMO Revenue (US$, Mn) & (2019-2024)
Table 49. Lonza Key News & Latest Developments
Table 50. Siegfried Company Summary
Table 51. Siegfried Active Pharmaceutical Ingredients (API) CDMO Product Offerings
Table 52. Siegfried Active Pharmaceutical Ingredients (API) CDMO Revenue (US$, Mn) & (2019-2024)
Table 53. Siegfried Key News & Latest Developments
Table 54. Catalent Company Summary
Table 55. Catalent Active Pharmaceutical Ingredients (API) CDMO Product Offerings
Table 56. Catalent Active Pharmaceutical Ingredients (API) CDMO Revenue (US$, Mn) & (2019-2024)
Table 57. Catalent Key News & Latest Developments
Table 58. Boehringer Ingelheim Company Summary
Table 59. Boehringer Ingelheim Active Pharmaceutical Ingredients (API) CDMO Product Offerings
Table 60. Boehringer Ingelheim Active Pharmaceutical Ingredients (API) CDMO Revenue (US$, Mn) & (2019-2024)
Table 61. Boehringer Ingelheim Key News & Latest Developments
Table 62. Piramal Group Company Summary
Table 63. Piramal Group Active Pharmaceutical Ingredients (API) CDMO Product Offerings
Table 64. Piramal Group Active Pharmaceutical Ingredients (API) CDMO Revenue (US$, Mn) & (2019-2024)
Table 65. Piramal Group Key News & Latest Developments
Table 66. AbbVie Company Summary
Table 67. AbbVie Active Pharmaceutical Ingredients (API) CDMO Product Offerings
Table 68. AbbVie Active Pharmaceutical Ingredients (API) CDMO Revenue (US$, Mn) & (2019-2024)
Table 69. AbbVie Key News & Latest Developments
Table 70. SGS Quay Pharmaceuticals Company Summary
Table 71. SGS Quay Pharmaceuticals Active Pharmaceutical Ingredients (API) CDMO Product Offerings
Table 72. SGS Quay Pharmaceuticals Active Pharmaceutical Ingredients (API) CDMO Revenue (US$, Mn) & (2019-2024)
Table 73. SGS Quay Pharmaceuticals Key News & Latest Developments
Table 74. Aenova Group Company Summary
Table 75. Aenova Group Active Pharmaceutical Ingredients (API) CDMO Product Offerings
Table 76. Aenova Group Active Pharmaceutical Ingredients (API) CDMO Revenue (US$, Mn) & (2019-2024)
Table 77. Aenova Group Key News & Latest Developments
Table 78. Curia Company Summary
Table 79. Curia Active Pharmaceutical Ingredients (API) CDMO Product Offerings
Table 80. Curia Active Pharmaceutical Ingredients (API) CDMO Revenue (US$, Mn) & (2019-2024)
Table 81. Curia Key News & Latest Developments
Table 82. Sterling Pharma Solutions Company Summary
Table 83. Sterling Pharma Solutions Active Pharmaceutical Ingredients (API) CDMO Product Offerings
Table 84. Sterling Pharma Solutions Active Pharmaceutical Ingredients (API) CDMO Revenue (US$, Mn) & (2019-2024)
Table 85. Sterling Pharma Solutions Key News & Latest Developments
Table 86. Eurofins CDMO Company Summary
Table 87. Eurofins CDMO Active Pharmaceutical Ingredients (API) CDMO Product Offerings
Table 88. Eurofins CDMO Active Pharmaceutical Ingredients (API) CDMO Revenue (US$, Mn) & (2019-2024)
Table 89. Eurofins CDMO Key News & Latest Developments
List of Figures
Figure 1. Active Pharmaceutical Ingredients (API) CDMO Segment by Type in 2023
Figure 2. Active Pharmaceutical Ingredients (API) CDMO Segment by Application in 2023
Figure 3. Global Active Pharmaceutical Ingredients (API) CDMO Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Active Pharmaceutical Ingredients (API) CDMO Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Active Pharmaceutical Ingredients (API) CDMO Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Active Pharmaceutical Ingredients (API) CDMO Revenue in 2023
Figure 8. By Type - Global Active Pharmaceutical Ingredients (API) CDMO Revenue Market Share, 2019-2030
Figure 9. By Application - Global Active Pharmaceutical Ingredients (API) CDMO Revenue Market Share, 2019-2030
Figure 10. By Type - Global Active Pharmaceutical Ingredients (API) CDMO Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Active Pharmaceutical Ingredients (API) CDMO Revenue Market Share, 2019-2030
Figure 12. By Application - Global Active Pharmaceutical Ingredients (API) CDMO Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Active Pharmaceutical Ingredients (API) CDMO Revenue Market Share, 2019-2030
Figure 14. By Region - Global Active Pharmaceutical Ingredients (API) CDMO Revenue Market Share, 2019-2030
Figure 15. By Country - North America Active Pharmaceutical Ingredients (API) CDMO Revenue Market Share, 2019-2030
Figure 16. US Active Pharmaceutical Ingredients (API) CDMO Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Active Pharmaceutical Ingredients (API) CDMO Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Active Pharmaceutical Ingredients (API) CDMO Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Active Pharmaceutical Ingredients (API) CDMO Revenue Market Share, 2019-2030
Figure 20. Germany Active Pharmaceutical Ingredients (API) CDMO Revenue, (US$, Mn), 2019-2030
Figure 21. France Active Pharmaceutical Ingredients (API) CDMO Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Active Pharmaceutical Ingredients (API) CDMO Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Active Pharmaceutical Ingredients (API) CDMO Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Active Pharmaceutical Ingredients (API) CDMO Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Active Pharmaceutical Ingredients (API) CDMO Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Active Pharmaceutical Ingredients (API) CDMO Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Active Pharmaceutical Ingredients (API) CDMO Revenue Market Share, 2019-2030
Figure 28. China Active Pharmaceutical Ingredients (API) CDMO Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Active Pharmaceutical Ingredients (API) CDMO Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Active Pharmaceutical Ingredients (API) CDMO Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Active Pharmaceutical Ingredients (API) CDMO Revenue, (US$, Mn), 2019-2030
Figure 32. India Active Pharmaceutical Ingredients (API) CDMO Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Active Pharmaceutical Ingredients (API) CDMO Revenue Market Share, 2019-2030
Figure 34. Brazil Active Pharmaceutical Ingredients (API) CDMO Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Active Pharmaceutical Ingredients (API) CDMO Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Active Pharmaceutical Ingredients (API) CDMO Revenue Market Share, 2019-2030
Figure 37. Turkey Active Pharmaceutical Ingredients (API) CDMO Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Active Pharmaceutical Ingredients (API) CDMO Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Active Pharmaceutical Ingredients (API) CDMO Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Active Pharmaceutical Ingredients (API) CDMO Revenue, (US$, Mn), 2019-2030
Figure 41. Recipharm Active Pharmaceutical Ingredients (API) CDMO Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Cambrex Corporation Active Pharmaceutical Ingredients (API) CDMO Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Patheon (Thermo Fisher Scientific) Active Pharmaceutical Ingredients (API) CDMO Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. CordenPharma Active Pharmaceutical Ingredients (API) CDMO Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Lonza Active Pharmaceutical Ingredients (API) CDMO Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Siegfried Active Pharmaceutical Ingredients (API) CDMO Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Catalent Active Pharmaceutical Ingredients (API) CDMO Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Boehringer Ingelheim Active Pharmaceutical Ingredients (API) CDMO Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Piramal Group Active Pharmaceutical Ingredients (API) CDMO Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. AbbVie Active Pharmaceutical Ingredients (API) CDMO Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 51. SGS Quay Pharmaceuticals Active Pharmaceutical Ingredients (API) CDMO Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 52. Aenova Group Active Pharmaceutical Ingredients (API) CDMO Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 53. Curia Active Pharmaceutical Ingredients (API) CDMO Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 54. Sterling Pharma Solutions Active Pharmaceutical Ingredients (API) CDMO Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 55. Eurofins CDMO Active Pharmaceutical Ingredients (API) CDMO Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
